Pneumonia Vaccines Protect Young and Old

The CDC now recommends two pneumococcal vaccines for adults 65 years or older: pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).

  • PCV13 is recommended for:
    • All children younger than 5 years old
    • All adults 65 years or older
    • Individuals 6 years or older with certain long-term health problems or a weakened immune system, including people with sickle cell disease, congenital or acquired asplenia, cerebrospinal fluid leaks and cochlear implants
  • PPSV23 is recommended for:
    • All adults 65 years or older
    • People 2 through 64 years old with certain long-term health problems or a weakened immune system, including:
      • Chronic diseases (i.e., cardiovascular, pulmonary, diabetes, alcoholism, liver disease, etc.)
      • Cerebrospinal fluid leaks or cochlear implants
      • Functional or anatomic asplenia, including sickle cell disease and congenital or acquired asplenia
      • Immunocompromising conditions, such as HIV infection, leukemia, lymphoma, Hodgkin's disease, kidney failure or organ transplant
      • Individuals currently taking a drug or treatment that lowers the body's resistance to infection, such as long-term steroids, certain cancer drugs or radiation therapy
      • Adults 19 through 64 years of age who smoke cigarettes or have asthma

    More information about the pneumonia vaccine, including coding guidelines, is available here.